Increased Risk of Second Primary Malignancies in Patients with Gynecological Cancer: A Swedish record-linkage study

References

• Curtis R E, Boice J D, Jr, Kleinerman R A, Flannery J T, Fraumeni J F, Jr. Summary: multiple primary cancers in Connecticut, 1935–82. Natl Cancer Inst Monogr 1985; 68: 219–42
   PubMedGoogle Scholar
• Curtis R E, Hoover R N, Kleinerman R A, Harvey E B. Second cancer following cancer of the female genital system in Connecticut, 1935–82. Natl Cancer Inst Monogr 1985; 68: 113–9
   PubMedGoogle Scholar
• Storm H H, Ewertz M. Second cancer following cancer of the female genital system in Denmark, 1943–80. Natl Cancer Inst Monogr 1985; 68: 331–40
   PubMedGoogle Scholar
• Kaldor J. Second cancer following chemotherapy and radiotherapy. An epidemiological perspective. Acta Oncol 1990; 29: 647–55
   PubMed Web of Science ®Google Scholar
• United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. UNSCEAR 1994 Report to the General Assembly, with scientific annexes. United Nations, New York 1994
   Google Scholar
• Schuman L M. Introduction and summary. Smoking and health. A report of the Surgeon General, J M Pinney. DHEW Publication No. (PHS) 79–50066, U.S. Department of Health, Education, and Welfare. Public Health Service, Washington, DC 1979; 5–35
   Google Scholar
• Baron J A, Byers T, Greenberg E R, Cummings K M, Swanson M. Cigarette smoking in women with cancers of the breast and reproductive organs. J Natl Cancer Inst 1986; 77: 677–80
   PubMedGoogle Scholar
• Miki Y, Swensen J, Shattuck‐Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCAI. Science 1994; 266: 66–71
   PubMed Web of Science ®Google Scholar
• Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non‐notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984; 23: 305–13
   PubMed Web of Science ®Google Scholar
• International classification of diseases, injuries and causes of death (ICD‐7), 1955 revision. World Health Organization, Geneva 1957
   Google Scholar
• Breslow N E, Day N E. Statistical methods in cancer research. Volume II—The design and analysis of cohort studies. International Agency for Research on Cancer, Lyon 1987
   Google Scholar
• Boffetta P, Kaldor J M. Secondary malignancies following cancer chemotherapy. Acta Oncol 1994; 33: 591–8
   PubMed Web of Science ®Google Scholar
• Schoen R E, Weissfeld J L, Kuller L H. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?. Am J Gastroenterol 1994; 89: 835–42
   PubMedGoogle Scholar
• Lynch H T, Lynch J F. Hereditary ovarian carcinoma. Hema‐tol Oncol Clin North Am 1992; 6: 783–811
   PubMed Web of Science ®Google Scholar
• Pross H F, Baines M G. Spontaneous human lymphocytemediated cytotoxicity against tumour target cells. I. The effect of malignant disease. Int J Cancer 1976; 18: 593–604
   PubMed Web of Science ®Google Scholar
• Brusamolino E, Pagnucco G, Bernasconi C. Secondary lymphomas. A review of lymphoproliferative diseases arising in immunocompromized hosts: prevalence, clinical features and pathogenetic mechanisms. Haematologica 1989; 74: 605–22
   PubMedGoogle Scholar
• Mabuchi K, Bross D S, Kessler I I. Epidemiology of cancer of the vulva. A case‐control study. Cancer 1985; 55: 1843–8
   PubMedGoogle Scholar
• Pettersson F, Ryberg M, Malker B. Second primary cancer after treatment of invasive carcinoma of the uterine cervix, compared with those rising after treatment for in situ carcinomas. An effect of irradiation? Acta Obstet Gynecol Scand 1990; 69: 161–74
   PubMed Web of Science ®Google Scholar
• Day N E, Boice J D, Jr. Summary chapter. Second cancer in relation to radiation treatment for cervical cancer, N E Day, J D Boice. IARC Scientific Publication No. 52, International Agency for Research on Cancer, Lyon 1983; 137–81
   Google Scholar
• Boice J D, Jr, Day N E, Andersen A, . Cancer risk following radiotherapy of cervical cancer: a preliminary report. Radiation carcinogenesis: epidemiology and biological significance, J D Boice, Jr, J F Fraumeni, Jr, et al. Raven Press, New York 1984; 161–79
   Google Scholar
• Pettersson F, Fotiou S, Einhorn N, Silfverswärd C. Cohort study of the long‐term effect of irradiation for carcinoma of the uterine cervix. Second primary malignancies in the pelvic organs in women irradiated for cervical carcinoma at Radiumhemmet 1914–1965. Acta Radiol Oncol 1985; 24: 145–51
   PubMed Web of Science ®Google Scholar
• zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1989; 49: 4677–81
   PubMed Web of Science ®Google Scholar
• Malker B, Pettersson F. Second primary cancers after treatment for cervical cancer. A study of 58 731 Swedish women with invasive or in‐situ cancer. Second cancer in relation to radiation treatment for cervical cancer, N E Day, J D Boice, Jr. IARC Scientific Publications No. 52, International Agency for Research on Cancer, Lyon 1983; 87–96
   Google Scholar
• Arai T, Nakano T, Fukuhisa K, et al. Second cancer after radiation therapy for cancer of the uterine cervix. Cancer 1991; 67: 398–405
   PubMed Web of Science ®Google Scholar
• Bailar J C, III. The incidence of independent tumors among uterine cancer patients. Cancer 1963; 16: 842–53
   PubMedGoogle Scholar
• Buchler D A. Multiple primaries and gynecologic malignancies. Am J Obstet Gynecol 1975; 123: 376–81
   PubMedGoogle Scholar
• Annegers J F, Malkasian G D, Jr. Patterns of other neoplasia in patients with endometrial carcinoma. Cancer 1981; 48: 856–9
   PubMedGoogle Scholar
• Ewertz M, Storm H H. Multiple primary cancers of the breast, endometrium and ovary. Eur J Cancer Clin Oncol 1989; 25: 1927–32
   PubMedGoogle Scholar
• Franceschi S. Reproductive factors and cancers of the breast, ovary and endometrium. Eur J Cancer Clin Oncol 1989; 25: 1933–43
   PubMedGoogle Scholar
• Vongtama V, Kurohara S S, Badib A O, Webster J H. Second primary cancers of endometrial carcinoma. Cancer 1970; 26: 842–6
   PubMedGoogle Scholar
• Curtis R E, Boice J D, Jr, Stovall M, et al. Relationship of leukemia risk to radiation dose following cancer of the uterine corpus. J Natl Cancer Inst 1994; 86: 1315–24
   PubMed Web of Science ®Google Scholar
• Nori D, Merimsky O, Batata M, Caputo T. Postoperative high dose‐rate intravaginal brachytherapy combined with external irradiation for early stage endometrial cancer: a longterm follow‐up. Int J Radiat Oncol Biol Phys 1994; 30: 831–7
   PubMedGoogle Scholar
• Reimer R R, Hoover R, Fraumeni J F, Jr, Young R C. Second primary neoplasms following ovarian cancer. J Natl Cancer Inst 1978; 61: 1195–7
   PubMedGoogle Scholar
• Prior P, Pope D J. Subsequent primary cancers in relation to treatment of ovarian cancer. Br J Cancer 1989; 59: 453–9
   PubMedGoogle Scholar
• Shah S, Evans D G R, Blair V, Burnell L D, Birch J M. Assessment of relative risk of second primary tumors after ovarian cancer and of the usefulness of double primary cases as a source of material for genetic studies with a cancer registry. Cancer 1993; 72: 819–27
   PubMedGoogle Scholar
• Kaldor J M, Day N E, Band P, et al. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer 1987; 39: 571–85
   PubMed Web of Science ®Google Scholar
• Einhorn N. Acute leukemia after chemotherapy (melphalan). Cancer 1978; 41: 444–7
   PubMed Web of Science ®Google Scholar
• Einhorn N, Eklund G, Franzén S, Lambert B, Lindsten J, Söderhäll S. Late side effects of chemotherapy in ovarian carcinoma. A cytogenetic, hematologic, and statistical study. Cancer 1982; 49: 2234–41
   PubMed Web of Science ®Google Scholar
• Kaldor J M, Day N E, Pettersson F, et al. Leukemia following chemotherapy for ovarian cancer. N Engl J Med 1990; 322: 1–6
   PubMed Web of Science ®Google Scholar